Joel Lewis Galectin Therapeutics Inc (GALT) insider trading activity
Joel Lewis is President and CEO of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 897,716 shares of GALT, which is worth approximately $2.52 Million. The most recent transaction as insider was on Jan 15, 2021, when has been sold 7,610 shares (Common Stock) at a price of $2.19 per share, resulting in proceeds of $16,666. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
898K
0%
3M change
10.09%
12M change
Total Value Held
$2.52 Million
JOEL LEWIS Transaction History
JL
Joel Lewis
President and CEO
Norcross, GA